Valuation: ABL Diagnostics

Market Cap 3.89Cr 4.49Cr 3.63Cr 3.32Cr 6.26Cr 428.43Cr 6.36Cr 43Cr 17Cr 214.33Cr 17Cr 16Cr 713.84Cr P/E 2024
123x
P/E 2025 50x
Enterprise Value 3.98Cr 4.6Cr 3.72Cr 3.4Cr 6.41Cr 438.7Cr 6.51Cr 44Cr 17Cr 219.47Cr 17Cr 17Cr 730.96Cr EV / Sales 2024
70,98,474x
EV / Sales 2025 61,85,843x
Free-Float
6.2%
Yield 2024
2.03%
Yield 2025 3.67%
1 day-2.42%
1 week-1.63%
1 month-3.97%
3 months+0.83%
6 months-25.77%
Current year-19.33%
1 week 2.4
Extreme 2.4
2.74
1 month 2.18
Extreme 2.18
2.74
Current year 2.12
Extreme 2.12
5
1 year 2.12
Extreme 2.12
5
3 years 2.12
Extreme 2.12
9.7
5 years 1.99
Extreme 1.9875
26
10 years 1.28
Extreme 1.275
26
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
20/07/26
Advanced Biological Laboratories SA
SellCompany -65,616 0.4072%
06/07/26
Advanced Biological Laboratories SA
SellCompany -62,308 0.3867%
13/02/26
Advanced Biological Laboratories SA
SellCompany 1,28,026 0.7945%
Change 5-day change 1-year change 3-year change Capi.($)
-2.42%-1.63%-46.22%-72.50% 4.49Cr
+0.75%+1.40%-19.11%+3.70% 19TCr
+2.58%+3.15%-3.74%+7.57% 11TCr
+1.42%+5.39%+13.98%+73.77% 6.2TCr
+2.38%+3.92%+35.52%+60.21% 5.53TCr
+1.57%+5.53%-7.17%-35.21% 4.89TCr
+3.42%+0.39%+11.15%-22.62% 3.31TCr
-4.03%-16.46% - - 2.97TCr
-0.55%+1.20%+46.12%-12.02% 2.48TCr
+0.61%+2.70%-1.62%+5.14% 2.33TCr
Average +0.57%+0.05%+3.21%+0.89% 5.79TCr
Weighted average by Cap. +1.25%+2.14%-0.12%+12.39%

Financials

2024 2025
Net sales 5.87 6.78 5.49 5.01 9.45 646.63 9.6 64.33 25.24 323.49 25.46 24.9 1.08T 7.97 9.2 7.45 6.8 12.82 877.57 13.02 87.31 34.26 439.03 34.55 33.8 1.46T
Net income 3L 3L 3L 2L 5L 3.14Cr 5L 31.26L 12.26L 1.57Cr 12.37L 12.1L 5.23Cr 10L 11.4L 9L 8L 15.88L 11Cr 16.13L 1.08Cr 42.44L 5.44Cr 42.8L 41.86L 18Cr
Net Debt 20.24L 23.38L 18.92L 17.29L 32.58L 22Cr 33.09L 2.22Cr 87.04L 11Cr 87.78L 85.87L 37Cr 9L 10.77L 9L 8L 15.01L 10Cr 15.25L 1.02Cr 40.11L 5.14Cr 40.45L 39.57L 17Cr
Logo ABL Diagnostics
ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.
Employees
22
Date Price Change Volume
10/26/10 €2.420 -2.42% 4,672
07/26/07 €2.480 -0.80% 1,787
06/26/06 €2.500 -3.10% 3,173
05/26/05 €2.580 +2.38% 7,728
04/26/04 €2.520 +2.44% 7,705

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABLD Stock